Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
CRCP encodes a membrane protein that functions as part of a receptor complex for a small neuropeptide that increases intracellular cAMP levels. De plus, nous expédions CGRP Receptor Component Protéines (10) et CGRP Receptor Component Kits (8) et beaucoup plus de produits pour cette protéine.
Showing 9 out of 11 products:
CGRP (Montrer CALCA Anticorps) can inhibit microglia activation in vivo in EAE. CGRP (Montrer CALCA Anticorps) and its receptor may represent novel protective factors in EAE.
CGRP-receptor component protein has been found to interact only with calcitonin (Montrer CALCA Anticorps)-like receptor and represents a novel neuroendocrine regulatory step in calcitonin gene-related peptide (Montrer CALCA Anticorps) signaling.
The mouse cDNA for calcitonin receptor-like receptor (CRLR (Montrer CALCRL Anticorps)) was cloned. The signal transduction mechanism through the CGRP (Montrer CALCA Anticorps) receptor was studied. mCRLR is a 462-amino acid G-protein-coupled heptahelical receptor (Montrer AGTR1 Anticorps).
data reinforce and clarify our understanding of CGRP (Montrer S100A12 Anticorps) receptor localization, and provide evidence that antagonist antibodies bind to target sites in the trigeminovascular system of primates that are involved in the pathology of migraine
CGRP (Montrer S100A12 Anticorps) family of receptors displays both ligand- and RAMP-dependent signaling bias among the Galphas (Montrer GNAS Anticorps), Galphai, and Galphaq (Montrer GNAQ Anticorps)/11 pathways.
In this review, the influence of the CGRP (Montrer S100A12 Anticorps) family peptides in reproduction and pregnancy is explored and discussed.
This study demonstrates the detailed expression of CGRP (Montrer S100A12 Anticorps) and its receptor components within spinal trigeminal nucleus in the brainstem and in the spinal cord at C1-level
The extracellular protein domains corresponding to residues 23-133 of calcitonin receptor-like receptor (Montrer CALCRL Anticorps) and residues 26-117 of receptor activity-modifying protein 1 (RAMP1 (Montrer RAMP1 Anticorps)) are shown to be sufficient for formation of a stable, folded monodisperse complex.
Data describe the role of residues 23-60 of the calcitonin receptor-like receptor (Montrer CALCRL Anticorps) in binding with interaction sites within the N-terminus of the calcitonin gene-related peptide (Montrer CALCA Anticorps) receptor.
Expression of CGRP-RCP was detected in CD34 (Montrer CD34 Anticorps)+ cells and also in some mature granulocyte samples, providing evidence that CGRP-RCP may be regulated independently of RAMP1 (Montrer RAMP1 Anticorps) and CRLR (Montrer CALCRL Anticorps) in hematopoietic cells.
human CGRP-RCP is the genuine orthologue of C17. CGRP-RCP was found to functionally replace C17 in Deltarpc17 yeast cells; CGRP-RCP was identified in a purified human Pol III preparation.
inhibition of ACE (Montrer ACE Anticorps) seems to augment CGRP (Montrer S100A12 Anticorps) catabolism.
Increased mRNA expression CGRP-RCP in gravid myometrium supports the possibility of involvement of CGRP (Montrer S100A12 Anticorps) in the control of myometrial contractility.
This gene encodes a membrane protein that functions as part of a receptor complex for a small neuropeptide that increases intracellular cAMP levels. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.
calcitonin gene-related peptide-receptor component protein
, DNA-directed RNA polymerase III subunit RPC9
, CGRP-receptor component protein
, RNA polymerase III subunit C9